Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-03-28Clinical Trial Update: Hypofractionated Radiation Therapy Combined With Concurrent Chemotherapy for Patients With Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating hypofractionated radiation therapy with concurrent chemotherapy for non-small cell lung cancer; the study …
-
CLINICAL_TRIALS trial_result · 2016-03-28Clinical Trial Update: An Observational Study of Tarceva (Erlotinib) in Routine Daily Clinical Practice as Second Line Treatment in Patients With Non-small Cell Lung Cancer
An observational study evaluating Tarceva (erlotinib) as second-line treatment for non-small cell lung cancer in routine daily clinical prac…
-
CLINICAL_TRIALS trial_result · 2016-03-23Clinical Trial Update: A Study Assessing Efficacy and Safety of SAR125844 in NSCLC Patients With MET Amplification [Phase 2]
This Phase 2 trial assessed the efficacy and safety of SAR125844 in non-small cell lung cancer patients with MET amplification and has compl…
-
CLINICAL_TRIALS trial_result · 2016-03-22Clinical Trial Update: Analysis of Treatment Outcome and Toxicity in Non-small Cell Lung Cancer Patients Wither-irradiated to a High Dose for Recurrent Disease
This clinical trial update analyzes outcomes and toxicity for patients with recurrent non-small cell lung cancer treated with high-dose re-i…
-
CLINICAL_TRIALS trial_result · 2016-03-22Clinical Trial Update: The Correlation Between MAGE-A3, PRAME Polymorphism and Expression Levels of MAGE-A3 and PRAME in NSCLC Patients
The study investigates correlations between MAGE-A3 and PRAME polymorphisms and their expression levels in non-small cell lung cancer, provi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Phase I/II Study of Fractionated Stereotactic Radiotherapy for Early Stage Non-Small Cell Lung Cancer [Phase 1, Phase 2]
This update reports the results of a Phase I/II study evaluating fractionated stereotactic radiotherapy for early-stage non-small cell lung …
-
CLINICAL_TRIALS trial_result · 2016-03-15Clinical Trial Update: A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS) [Phase 3]
Phase 3 ATLAS trial comparing bevacizumab with or without erlotinib as first-line therapy for non-small cell lung cancer; results have been …
-
CLINICAL_TRIALS trial_result · 2016-03-10Clinical Trial Update: Efficacy Study of Avastin® With Pemetrexed +/- Carboplatin to Treat Elderly Patients With Non-small Cell Lung Cancer [Phase 3]
A Phase 3 trial evaluated Avastin (bevacizumab) in combination with pemetrexed, with or without carboplatin, in elderly patients with non-sq…
-
CLINICAL_TRIALS trial_result · 2016-03-10Clinical Trial Update: Chemoradiotherapy of NSCLC Stage IIIB [Phase 2]
A Phase 2 trial of concomitant chemoradiotherapy for stage IIIB non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-10Clinical Trial Update: Stage I/II NSCLC Perioperative Chemotherapy [Phase 3]
A Phase 3 clinical trial evaluating perioperative chemotherapy for Stage I/II non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-09Clinical Trial Update: Asia Pacific and Russia Diagnostic Study for EGFR Testing [NA]
This clinical trial in Asia Pacific and Russia evaluated EGFR mutation testing in advanced non-small cell lung cancer, with results posted i…
-
CLINICAL_TRIALS trial_result · 2016-03-07Clinical Trial Update: Non Small Cell Lung Cancer Patients Treated With Erlotinib Six Months or Longer
The update reports outcomes for non-small cell lung cancer patients who received erlotinib for six months or longer in a completed study.
-
CLINICAL_TRIALS trial_result · 2016-03-04Clinical Trial Update: Safety and Efficacy Study of Avastin in Locally Advanced Metastatic or Recurrent Non-small Lung Cancer (NSLC) Participants
This clinical trial update reports safety and efficacy results for bevacizumab (Avastin) in locally advanced, metastatic, or recurrent non-s…
-
CLINICAL_TRIALS trial_result · 2016-03-03Clinical Trial Update: Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) [Phase 3]
Phase III study evaluating GTx-024 (enobosarm) for muscle wasting in patients with non-small cell lung cancer; results were posted in March …
-
CLINICAL_TRIALS trial_result · 2016-03-02Clinical Trial Update: A Study of AUY922 in Non-small-cell Lung Cancer Patients Who Have Received Previous Two Lines of Chemotherapy. [Phase 2]
A completed Phase 2 trial of AUY922 (ganetespib) in non-small cell lung cancer after two prior chemotherapies has posted results (2016-03-02…
-
CLINICAL_TRIALS trial_result · 2016-03-02Clinical Trial Update: Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma [Phase 1]
Phase 1 trial of a cancer vaccine therapy with GM-CSF in patients with acute myeloid leukemia, myelodysplastic syndromes, non-small cell lun…
-
CLINICAL_TRIALS trial_result · 2016-03-01Clinical Trial Update: Docetaxel With or Without FGFR Inhibitor AZD4547 in Treating Patients With Recurrent Non-Small Cell Lung Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating docetaxel with or without the FGFR inhibitor AZD4547 in recurrent non-small cell lung cancer, includin…
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery [Phase 2]
Phase 2 trial results evaluating the combination of chemotherapy, radiation therapy, and bevacizumab in newly diagnosed, unresectable stage …
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: A Study of First-line Maintenance Erlotinib Versus Erlotinib at Disease Progression in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) Who Have Not Progressed Following Platinum-Based Chemotherapy [Phase 3]
A Phase 3 trial compares maintenance erlotinib versus erlotinib at progression in advanced non-small cell lung cancer after platinum therapy…
-
CLINICAL_TRIALS trial_result · 2016-02-26Clinical Trial Update: Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Metastatic Non-squamous NSCLC [Phase 3]
Phase 3 trial comparing nivolumab to docetaxel in previously treated metastatic non-squamous non-small cell lung cancer has completed with r…
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: Self-Gated Breath-Hold Technique for Helical Tomotherapy in Patients With Non-Small Cell Lung Cancer [Phase 1]
Phase 1 clinical trial evaluating a self-gated breath-hold technique during helical tomotherapy in non-small cell lung cancer has completed.…
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients Receiving a Treatment Planning Study of 3 Dimensional Conformal Radiation Therapy Guided by Breath Held CT and PET Imaging for Patients With Non-Small Cell Lung Cancer [Phase 2]
Phase 2 study evaluating 18F-fluorodeoxyglucose imaging (FluGlucoScan) to guide three-dimensional conformal radiation therapy with breath-he…
-
CLINICAL_TRIALS trial_result · 2016-02-23Clinical Trial Update: Clinical Value of Sequential Gefitinib With Pemetrexed/Platinum for Advanced NSCLC [Phase 2, Phase 3]
A completed Phase 2/Phase 3 study evaluating sequential gefitinib followed by pemetrexed plus platinum in advanced non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2016-02-23Clinical Trial Update: Iressa Re-Challenge in Advanced NSCLC EGFR M+ Patients Who Responded to Gefitinib USed as 1st Line or Previous Treatment [Phase 2]
Phase 2 study evaluating re-challenge with gefitinib (Iressa) in advanced EGFR-mutant non-small cell lung cancer patients who previously res…
-
CLINICAL_TRIALS trial_result · 2016-02-23Clinical Trial Update: Safety and Efficacy of DC-CIK in Patients With Advanced Non-Small-Cell Lung Cancer With Bone Metastases [Phase 1, Phase 2]
An update on the safety and efficacy of DC-CIK cell therapy in patients with advanced non-small-cell lung cancer with bone metastases, spann…